Fig. 1From: Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutationsStudy cohort. The data are the number of patients, unless specified otherwise. The thick framed square indicates the full analysis set of this studyBack to article page